MYELOPROLIFERATIVE SYNDROME
Clinical trials for MYELOPROLIFERATIVE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE SYNDROME trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Suicide-Gene t cells aim to stop blood cancer relapse
Disease control Recruiting nowThis early-phase trial tests whether infusing specially designed immune cells can prevent blood cancer from coming back after a stem cell transplant. The cells target a specific protein (HLA-DPB1*04:01) found on many cancer cells and include a 'suicide switch' to turn them off if…
Matched conditions: MYELOPROLIFERATIVE SYNDROME
Phase: PHASE1 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
New stem cell combo aims to beat childhood cancers
Disease control Recruiting nowThis early-phase trial tests a new type of stem cell transplant for children with blood cancers or solid tumors that have relapsed or not responded to standard treatment. Doctors use a half-matched donor's stem cells, specially filtered to remove certain immune cells, and give th…
Matched conditions: MYELOPROLIFERATIVE SYNDROME
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Poop pills to prevent transplant rejection? new trial tests fecal transplants in blood cancer patients
Prevention Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) can prevent graft-versus-host disease (GvHD) in 150 adults with blood cancers who receive a stem cell transplant. Patients get a single FMT enema within four weeks of transplant. The main goal is to see if FMT improves …
Matched conditions: MYELOPROLIFERATIVE SYNDROME
Phase: PHASE2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Gene mapping of childhood blood cancers could unlock personalized treatments
Knowledge-focused Recruiting nowThis research study collects and analyzes blood and bone marrow samples from children and young adults with leukemia, myelodysplastic syndrome, or myeloproliferative syndrome. By reading the genetic instructions in these cancer cells, scientists hope to understand why the disease…
Matched conditions: MYELOPROLIFERATIVE SYNDROME
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC